September 22, 2026 | ASCO, Congress, Pharma, healthcare, oncology
As the oncology landscape continues to evolve, life sciences organizations face a growing challenge: how do you communicate increasingly complex science in a way that creates meaningful engagement?

The pace of innovation in oncology is accelerating, bringing more data, more complex science, and more information for HCPs to navigate.
Our latest oncology congress eBook explores what this means for life sciences organizations and how congress experiences can help turn scientific innovation into understanding.
Discover insights on:
Making meaningful connections in an age of accelerated innovation
Creating more effective congress experiences
The future of congress engagement for life sciences companies
Emerging trends shaping oncology commercialization
Why a connected approach is key to congress success
This content was provided by Inizio
Latest Content from Inizio
SLE is a progressive and debilitating disease which affects 5 million people worldwide.
Pegasus, an Ashfield company, part of UDG Healthcare plc, is proud to announce the launch of its new propriety model for planning in health – CHANGE – which was developed…
Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics
Published in eyeforpharma January 2017 by Mariel Metcalfe
Published in Pharmaphorum January 2017
We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London
Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger…
We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.
Our client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range…
Published in eyeforpharma December 2016 by Marc Yates
